Breast Re-irradiation After Second Ipsilateral Lumpectomy

The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.

Trial Details

NCT ID
NCT06867484
Phase
NA
Sponsor
Youssef Zeidan
Status
RECRUITING
Cancer Type
HER2 Positive Breast Cancer
Interventions
  • Intensity modulated radiation therapy (IMRT)
Locations (sample)
  • Boca Raton, Florida, United States|26.35869,-80.0831
  • Miami, Florida, United States|25.77427,-80.19366

Key Eligibility Criteria

  • Diagnosed with ER+HER2- breast cancer
  • Provision of signed and dated ICF
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Age ≥ 40 years

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find HER2 Positive Breast Cancer Trials on Trialify →